Pieris Pharmaceuticals, Inc. (PIRS)

NASDAQ: PIRS · IEX Real-Time Price · USD

0.145

-0.010 (-6.45%)

At close: Apr 19, 2024, 4:00 PM

0.147

+0.002 (1.38%)

After-hours: Apr 19, 2024, 7:59 PM EDT

Pieris Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-24.54	-33.28	-45.74	-37.23	-28.3	-26.75	-17.65	-22.8	-14.06	-9.85	Upgrade
Depreciation & Amortization	1.78	2.78	2.37	2.13	1.04	0.57	0.37	0.36	0.31	0.37	Upgrade
Share-Based Compensation	3.35	4.4	5.22	5.09	5.37	4.94	3.05	1.91	1.16	0.57	Upgrade
Other Operating Activities	-34.41	-33.84	30.5	-15.88	-33.41	20.18	63.99	6.15	-0.12	3.85	Upgrade
Operating Cash Flow	-53.82	-59.93	-7.66	-45.9	-52.47	-1.07	49.75	-14.39	-12.71	-5.07	Upgrade
Capital Expenditures	-0.17	-1.04	-0.95	-2.73	-2.46	-1.7	-1.95	-0.56	-0.62	-0.27	Upgrade
Change in Investments	12.17	-20.2	0	41.94	12.3	-7.18	-43.93	0	0	0	Upgrade
Investing Cash Flow	12	-21.24	-0.95	39.21	9.84	-8.88	-45.88	-0.56	-0.62	-0.27	Upgrade
Share Issuance / Repurchase	19.8	7.21	59.13	10.12	32.17	48.51	4.09	15.22	25.77	11.96	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	0	-1.16	1.03	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-	7.34	Upgrade
Financing Cash Flow	19.8	7.21	59.13	10.12	32.17	48.51	4.09	15.22	24.62	20.33	Upgrade
Exchange Rate Effect	0.78	-5.18	-3.19	4.75	-2.14	-1.58	0.55	-0.27	-0.41	-0.22	Upgrade
Net Cash Flow	-21.24	-79.13	47.33	8.18	-12.61	36.99	8.52	0.01	10.87	14.78	Upgrade
Free Cash Flow	-53.99	-60.97	-8.61	-48.62	-54.93	-2.76	47.8	-14.95	-13.33	-5.33	Upgrade
Free Cash Flow Margin	-126.12%	-235.40%	-27.40%	-165.82%	-118.69%	-9.50%	189.14%	-256.35%	-454.52%	-99.40%	Upgrade
Free Cash Flow Per Share	-0.60	-0.82	-0.13	-0.89	-1.08	-0.05	1.09	-0.36	-0.39	-0.38	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).